Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-31

Clinical Trial Update: Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions [NA]

View source ↗

Summary

This clinical trial update indicates that the Orsiro Mission 48-mm sirolimus-eluting coronary stent system is currently recruiting to assess safety and efficacy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System (Sirolimus-eluting coronary stent system)

Snippet

Sponsor: Teleflex | Conditions: Coronary Artery Disease | NA | Status: RECRUITING